Search Results - W. Small

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    FORMULATION STRATEGIES FOR ENHANCED TOPICAL BIOAVAILABILITY by W. Small

    Get full text
    Article


  2. 2

    Comments on “The possible pathogenesis of macular caldera in patients with North Carolina macular dystrophy” by Kent W. Small

    Published in BMC Ophthalmology (2023-09-01)
    Get full text
    Article


  3. 3

    Letter to the Editor Regarding: "Modern diagnostic and therapeutic approaches in familial maculopathy with reference to North Carolina macular dystrophy" by Jana Nekolova et al. by Kent W. Small

    Published in Biomedical Papers (2023-03-01)
    Get full text
    Article


  4. 4

    Comment on Spedicati et al. Hidden in the Genome: The First Italian Family with North Carolina Macular Dystrophy Carrying a Novel <i>PRDM13</i> and <i>CCNC</i> Duplication. <i>Biom... by Kent W. Small

    Published in Biomedicines (2026-05-01)
    Get full text
    Article


  5. 5

    Two fluocinolone implants adherent to the macula and each other by Kent W. Small, Jessica Avetisjan, Fadi S. Shaya

    Get full text
    Article


  6. 6

    Peripapillary Retinal Nerve Fiber Measurement with Spectral-Domain Optical Coherence Tomography in Age-Related Macular Degeneration by Simon K. Law, Kent W. Small, Joseph Caprioli

    Published in Vision (2017-12-01)
    Get full text
    Article


  7. 7

    Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells by George W. Small, Howard L. McLeod, Kristy L. Richards

    Published in PeerJ (2013-02-01)
    Get full text
    Article


  8. 8

    Understanding barriers to and facilitators of clinician-patient conversations about brain health and cognitive concerns in primary care: a systematic review and practical considera... by Soo Borson, Gary W. Small, Quentin O’Brien, Andrea Morrello, Malaz Boustani

    Published in BMC Primary Care (2023-11-01)
    Get full text
    Article


  9. 9

    Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel by Rajesh Pahwa, Stuart H. Isaacson, Gary W. Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh

    Published in Neurology and Therapy (2022-07-01)
    Get full text
    Article


  10. 10

    Correction to: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel by Rajesh Pahwa, Stuart H. Isaacson, Gary W. Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh

    Published in Neurology and Therapy (2023-07-01)
    Get full text
    Article


  11. 11

    Modifiable risk factors for Alzheimer disease and subjective memory impairment across age groups. by Stephen T Chen, Prabha Siddarth, Linda M Ercoli, David A Merrill, Fernando Torres-Gil, Gary W Small

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  12. 12

    Two-Step Constitutional Isomerization of Saturated Cyclic Amines Using Borane Catalysis by Charis Amber, Timothée M. Petitjean, Giedre Sirvinskaite, Ryan T. Steele, Breanna Sprague, Julius Domack, David W. Small, Richmond Sarpong

    Published in JACS Au (2025-01-01)
    Get full text
    Article


  13. 13

    DNA Ligase IV Guides End-Processing Choice during Nonhomologous End Joining by Michael P. Conlin, Dylan A. Reid, George W. Small, Howard H. Chang, Go Watanabe, Michael R. Lieber, Dale A. Ramsden, Eli Rothenberg

    Published in Cell Reports (2017-09-01)
    Get full text
    Article


  14. 14

    High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple antic... by Farida S Akhtari, Adrian J Green, George W Small, Tammy M Havener, John S House, Kyle R Roell, David M Reif, Howard L McLeod, Timothy Wiltshire, Alison A Motsinger-Reif

    Published in PLoS Genetics (2021-08-01)
    Get full text
    Article


  15. 15

    <i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients by Ricardo D. Gonzalez, George W. Small, Adrian J. Green, Farida S. Akhtari, Alison A. Motsinger-Reif, Julia C. F. Quintanilha, Tammy M. Havener, David M. Reif, Howard L. McLeod, Tim Wiltshire

    Published in Pharmaceuticals (2023-05-01)
    Get full text
    Article


  16. 16

    Pharmacogenomic Analyses Implicate B Cell Developmental Status and <i>MKL1</i> as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy by George W. Small, Farida S. Akhtari, Adrian J. Green, Tammy M. Havener, Michael Sikes, Julia Quintanhila, Ricardo D. Gonzalez, David M. Reif, Alison A. Motsinger-Reif, Howard L. McLeod, Tim Wiltshire

    Published in Cells (2023-06-01)
    Get full text
    Article


  17. 17

    <i>RYK</i> Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients by Ricardo D. Gonzalez, George W. Small, Adrian J. Green, Farida S. Akhtari, Tammy M. Havener, Julia C. F. Quintanilha, Amber B. Cipriani, David M. Reif, Howard L. McLeod, Alison A. Motsinger-Reif, Tim Wiltshire

    Published in Pharmaceuticals (2023-05-01)
    Get full text
    Article


  18. 18

    Life Extension Factor Klotho Enhances Cognition by Dena B. Dubal, Jennifer S. Yokoyama, Lei Zhu, Lauren Broestl, Kurtresha Worden, Dan Wang, Virginia E. Sturm, Daniel Kim, Eric Klein, Gui-Qiu Yu, Kaitlyn Ho, Kirsten E. Eilertson, Lei Yu, Makoto Kuro-o, Philip L. De Jager, Giovanni Coppola, Gary W. Small, David A. Bennett, Joel H. Kramer, Carmela R. Abraham, Bruce L. Miller, Lennart Mucke

    Published in Cell Reports (2014-05-01)
    Get full text
    Article


Search Tools: